Mergers and Acquisitions

Valeant sweetened its takeover bid for Botox maker Allergan, offering to buy the company for $49.4 billion.

Flint Hills Resources, a subsidiary of Koch Industries, agreed to buy PetroLogistics for $2.1 billion in cash, expanding its chemicals business.

Chicken producer Pilgrim’s Pride offered to acquire Hillshire Brands for $6.4 billion, potentially throwing a wrench into Hillshire’s plans to buy Pinnacle Foods.

AstraZeneca shares slumped Tuesday after Pfizer said it would not make a formal bid to acquire its smaller British rival.

Hess agreed to sell its gas stations and convenience stores to Marathon Petroleum's Speedway for $2.6 billion, as the energy producer turns its attention to drilling.

Google is buying Divide, a startup that helps businesses manage their employees’ mobile devices, as it looks to ramp up its Android division. 

Johnson Controls plans to spin off its auto-interiors business into a joint venture with a Chinese partner, as the diversified manufacturer shifts its focus to other units.

AstraZeneca rejected Pfizer’s final takeover offer on Monday, saying it still undervalues the drug giant. 

Darden Restaurants agreed to sell its Red Lobster chain to private equity firm Golden Gate Capital for $2.1 billion, as the restaurant operator pushes forward with plans to reshape its portfolio.

AstraZeneca's chief executive said his company's board would consider a compelling offer from Pfizer, despite turning down previous offers from the firm.

Valeant plans to unveil an improved offer for Botox maker Allergan later this month, as the Canadian drug company seeks to rally shareholder support for a buyout.

AT&T could seal a deal to acquire satellite television company DirecTV in the next two weeks, according to a report in The Wall Street Journal.

Mondelez agreed to merge its coffee business with D.E. Master Blenders, forming a new company that can better compete with Nestle and allowing Mondelez to focus on its snack portfolio.

Freeport-McMoRan Copper & Gold will sell its Eagle Ford Shale assets to Canada's Encana for $3.1 billion.

Merck agreed to sell its consumer-care unit to German pharmaceutical giant Bayer for $14.2 billion, continuing a flurry of healthcare deals.

AstraZeneca turned down a sweetened buyout offer of $106.4 billion from rival drug giant Pfizer, thwarting a move that would have created the world’s largest pharmaceutical company.

Botox-maker Allergan is reportedly hunting for a white knight after Valeant made a hostile buyout offer backed by Bill Ackman. 

The medical-device maker said it would acquire orthopedic products company Biomet in a deal valued at about $13.35 billion.

Pharmaceutical companies have been announcing deals at breakneck speeds this year in what analysts say is an attempt to hedge risk and hike profits.

Novartis said it will swap assets with GlaxoSmithKline and sell its animal health arm in a bid to simplify its business.